How is the Carisma Therapeutics Inc today?

The Carisma Therapeutics Inc today is trading in the down by -10.00% at 0.18.

How has Carisma Therapeutics Inc performed historically?

The Carisma Therapeutics Inc is currently trading down -10.00% on an intraday basis in the past week the index fell 0.00%. The index has been down -55.00% in the past quarter and fell -86.47% in the past year. You can view this in the overview section.

What is Carisma Therapeutics Inc Annual Revenue?

Carisma Therapeutics Inc Annual Revenue rose 31.59%, in the last year to $19.63 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Carisma Therapeutics Inc Annual Net Profit?

Carisma Therapeutics Inc Annual Net Profit rose 30.39% in the last year to $60.48 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Carisma Therapeutics Inc Price to Earning Ratio?

Carisma Therapeutics Inc Price to Earning Ratio is -0.15, which is negative.

What is Carisma Therapeutics Inc Stock Price?

Carisma Therapeutics Inc Stock Price fell 86.47% and underperformed its sector by 113.01% in the past year.

What is Carisma Therapeutics Inc Quarterly Revenue?

Carisma Therapeutics Inc Quarterly Revenue rose 9.77% YoY to $3.73 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Carisma Therapeutics Inc Quarterly Net profit?

Carisma Therapeutics Inc Quarterly Net profit rose 51.18% YoY to $9.27 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Carisma Therapeutics Inc Mutual Fund Holding?

Carisma Therapeutics Inc Mutual Fund Holding increased by 1.37% in the last quarter to 9.93.

What is Carisma Therapeutics Inc Institutional Holding?

Carisma Therapeutics Inc Institutional Holding increased by 1.93% in the last quarter to 16.66.

Carisma Therapeutics Inc XNAS: CARM

Carisma Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Carisma Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Carisma Therapeutics Inc
Rating: 1.02958325
Author: Trendlyne DVM scores

about

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and oth...

0.18 -0.02 (-10.00%)

90.53% Fall from 52W High

766.6K XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Carisma Therapeutics Inc is on 13 Jun 2025 for the purpose of CARISMA Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

15.8 / 100

Technically Bearish

25.4 / 100

1Yr Price target upside is 456%

1 analysts

Carisma Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Carisma Therapeutics Inc Live Share Price Today, Share Analysis and Chart

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and oth...

90.53% Fall from 52W High

SWOT Analysis

Carisma Therapeutics Inc Live Price Chart

Carisma Therapeutics Inc FAQ

How is Carisma Therapeutics Inc today?

Carisma Therapeutics Inc today is trading in the red, and is down by -10.00% at 0.18.

How has Carisma Therapeutics Inc performed historically?

Carisma Therapeutics Inc is currently trading down -10.00% on an intraday basis. In the past week the stock fell 0.00%. stock has been down -55.00% in the past quarter and fell -86.47% in the past year. You can view this in the overview section.